Page last updated: 2024-11-05

2-isopropylphenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Isopropylphenol, also known as o-isopropylphenol, is an organic compound with the formula CH3CH(CH3)C6H4OH. It is a colorless liquid that is slightly soluble in water. 2-Isopropylphenol is a common industrial chemical used in the production of resins, antioxidants, and other chemicals. It is also a component of some essential oils. 2-Isopropylphenol can be synthesized by the alkylation of phenol with isopropyl alcohol. It is a common intermediate in the synthesis of other chemicals, such as bisphenol A. 2-Isopropylphenol is also a known environmental pollutant. It can be found in wastewater from industrial processes, as well as in the atmosphere. 2-Isopropylphenol is known to be toxic to aquatic organisms and can cause skin and eye irritation in humans. 2-Isopropylphenol is studied for its potential health effects, including its role in the development of cancer. It is also studied for its environmental impact, such as its ability to contaminate water sources.'

2-isopropylphenol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-isopropylphenol : A member of the class of phenols carrying an isopropyl group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6943
CHEMBL ID30018
CHEBI ID38506
SCHEMBL ID43297
SCHEMBL ID8988162
MeSH IDM0240999

Synonyms (80)

Synonym
ortho-isopropylphenol
phenol, o-isopropyl-
isopropylphenol, ortho
2-isopropylphenol
nsc-5103
nsc5103
phenol, 2-(1-methylethyl)-
1-hydroxy-3-isopropylbenzene
1-hydroxy-2-isopropylbenzene
88-69-7
o-cumenol
o-isopropylphenol
isopropylphenol
2-(1-methylethyl)phenol
CHEBI:38506 ,
o-hydroxycumene
2-(propan-2-yl)phenol
inchi=1/c9h12o/c1-7(2)8-5-3-4-6-9(8)10/h3-7,10h,1-2h
isopropylphenol, o-
prodox 131
einecs 201-852-8
ai3-18550
nsc 5103
brn 1363322
cumenol, o-
fema no. 3461
2-isopropylphenol, >=98%, fg
2-isopropylphenol, 98%
25168-06-3
ip0 ,
CHEMBL30018 ,
2-isopropyl-phenol
2-propan-2-ylphenol
I0173
2-hydroxycumene
AKOS000120752
unii-b2899z0q2u
4-06-00-03210 (beilstein handbook reference)
b2899z0q2u ,
dtxcid0024391
NCGC00255940-01
cas-88-69-7
tox21_302062
dtxsid2044391 ,
o-isopropyl phenol
2-isopropyl phenol
unii-7ud6mug48s
7ud6mug48s ,
einecs 246-699-8
phenol, isopropyl-
bdbm50409533
BP-10159
FT-0627494
FT-0612721
isopropylphenol, 2-
2-isopropylphenol [fhfi]
metacresol impurity h [ep impurity]
propofol impurity c [ep impurity]
ortho-isopropyl phenol
2-iso-propylphenol
0-isopropyl phenol
isopropyl phenol
cumenol
SCHEMBL43297
3F36
SCHEMBL8988162
W-100389
STL453618
F0001-2189
mfcd00002224
2-(1-methylethyl)phenol; propofol imp. c (ep); propofol impurity c
isopropyl-phenol
o-isopropyl-phenol
2-(1-methylethyl)phenol, 9ci
fema 3461
2-(1-methylethyl)-phenol
Q27117882
EN300-20953
PD055451
Z104485440
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
2-isopropylphenol degradation311

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
farnesoid X nuclear receptorHomo sapiens (human)Potency54.94100.375827.485161.6524AID743220
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.24340.000323.4451159.6830AID743066
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Chain A, Ferritin light chainEquus caballus (horse)Kd1,300.0000460.00004,612.000016,500.0000AID977611
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)EC50 (µMol)99.14980.00112.000910.0000AID72641; AID72642
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)EC50 (µMol)99.14980.00141.957810.0000AID72641; AID72642
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)EC50 (µMol)99.14980.00141.776810.0000AID72641; AID72642
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
post-embryonic developmentGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
adult behaviorGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chemical synaptic transmissionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inner ear receptor cell developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
innervationGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cochlea developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
GABA receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
protein bindingGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
axonGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
extracellular exosomeGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (49)

Assay IDTitleYearJournalArticle
AID1173493Reduction Li-pilocarpine-induced weight loss in non-protected CF1 albino mouse at 65 mg/kg, ip after 0.5 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID72642Potentiation of GABA responses at human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID610661Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 1 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 89 +/- 1 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID282833Activity against caspase-mediated apoptosis in mouse L1210 cells at 0.1 mM2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID114276Hypnotic activity was measured as dose which causes loss of righting reflex for a minimum period of 30s in 50% of mice; Range is 30-401980Journal of medicinal chemistry, Dec, Volume: 23, Issue:12
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID610668Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 10 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 89 +/- 1 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID282834Activity against caspase-mediated apoptosis in mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID610706Cytotoxicity against human AU565 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1173469Anticonvulsant activity against CF1 albino mouse seizure model assessed as time to peak effect at 100 mg/kg, ip by 6 Hz psychomotor seizure test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173490Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 4 hrs by scMET test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1173481Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 2 hrs by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID610670Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 10 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 1.8 +/- 0.3 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID447577Agonist activity at GABAA assessed as enhancement of channel current2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
AID1173492Reduction Li-pilocarpine-induced weight loss in protected CF1 albino mouse at 65 mg/kg, ip after 0.5 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173467Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 0.25 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173480Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 1 hrs by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID72641Direct activation of human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID1173484Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 2 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID610703Growth inhibition of human MDA-MB-361 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID610671Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 1 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 9.2 +/- 0.8 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID610669Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 1 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 1.8 +/- 0.3 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1173470Anticonvulsant activity against ip dosed CF1 albino mouse seizure model after 4 hrs by 6 Hz psychomotor seizure test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID610704Cytotoxicity against human MDA-MB-361 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID15880Calculated partition coefficient (clogP)2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID1173482Neurotoxicity in CF1 albino mouse seizure model at 100 mg/kg, ip after 4 hrs by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173473Protective index, ratio of TD50 for CF1 albino mouse neurotoxicity to ED50 for protection against 6 Hz electroshock-induced seizure in CF1 albino mouse2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID447576Binding affinity to apoferritin by isothermal titration calorimetry2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
AID1173489Anticonvulsant activity in CF1 albino mouse assessed as protection against pentylenetetrazole-induced seizure at 100 mg/kg, ip after 2 hrs by scMET test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1173468Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 0.5 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1173472Neurotoxicity in ip dosed CF1 albino mouse seizure model after 4 hr by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID610662Cytotoxicity against human MCF7 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1173471Neurotoxicity in CF1 albino mouse seizure model assessed as time to peak toxic effect at 100 mg/kg, ip after 4 hr by rototod test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID1149269Antimicrobial activity against Aspergillus niger1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Quantitative structure-activity relationships. 2. A mixed approach, based on Hansch and Free-Wilson Analysis.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID610672Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 10 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 9.2 +/- 0.8 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1173483Anticonvulsant activity in CF1 albino mouse assessed as protection against maximal electroshock-induced seizures at 100 mg/kg, ip after 1 hrs2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Seizure prevention by the naturally occurring phenols, carvacrol and thymol in a partial seizure-psychomotor model.
AID610705Growth inhibition of human AU565 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID219761Loss of righting reflex (LORR) in tadpoles was determined for anesthetic activity2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.
AID116727Acute toxicity measured as median lethal dose in mice; Range is 100-1201980Journal of medicinal chemistry, Dec, Volume: 23, Issue:12
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.
AID610708Cytotoxicity against human HMEC cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID610667Growth inhibition of human MCF7 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID610707Growth inhibition of human HMEC cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009The Journal of biological chemistry, Sep-04, Volume: 284, Issue:36
A unitary anesthetic binding site at high resolution.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (23.08)18.7374
1990's1 (7.69)18.2507
2000's7 (53.85)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.19 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index39.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]